Steve Chaussy, Chief Financial Officer at BioSig Technologies, Inc. (BSGM), bought 400 shares at $1.81 ($724) on 2016-05-19, disclosed to the SEC on 2016-05-20.
Open-market purchase of $724 BSGM by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| BSGM | BUY | 2021-05-24 | $7K | — | Filing → |
| BSGM | BUY | 2020-12-02 | $9K | — | Filing → |
| BSGM | BUY | 2020-03-19 | $6K | — | Filing → |